Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: Post hoc analysis of the Irbesartan Diabetic Nephropathy Trial
"Research Use Only" (RUO) supply is a completely separate channel from legitimate clinical compounding, and selling RUO product for human consumption is a serious compliance problem
Your thyroid function may slow temporarily
Alcohol can worsen common GLP-1 side effects like nausea, vomiting, acid reflux, dehydration and low blood sugar, especially if you're eating less than usual
Lilly's massive R&D budget has also allowed it to focus on retatrutide, a so-called "triple-agonist" combining GLP-1 properties with other medications, that is currently in trial.
Patients who maintain higher protein intake and regular resistance training during treatment tend to preserve lean muscle mass better while losing fat